InVivo Therapeutics Co-Founder Dr. Robert Langer To Highlight InVivo Scientific Progress In Keynote At 2015 TERMIS World Congress

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) has announced that Co-Founder Robert Langer, Sc.D., will make a keynote address and highlight InVivo’s scientific progress at the 2015 Tissue Engineering & Regenerative Medicine International Society (TERMIS) World Congress in Boston on Wednesday, September 9, 2015.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC